KOPPEL ADAM purchased 7.4% of their position (1.56M shares) of KAILERA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $25.00M — a moderate purchase. The strongest form of insider conviction signal.
Common Stock
Shares
+16.88M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+4.15M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+1.56M
Price / share
$16.00
Trade value
$25M
% of position
Net shares
+22.58M
Net value
$25M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 4/20/2026 | C · Conversion | +16.88M | — | — | New position | 0.00 | 16.88M |
| Common Stock Indirect | 4/20/2026 | C · Conversion | +4.15M | — | — | 24.6% | 16.88M | 21.02M |
| Common Stock Indirect | 4/20/2026 | P · Purchase | +1.56M | $16.00 | $25M | 7.4% | 21.02M | 22.58M |
| Total | +22.58M | $25M | ||||||
Stock Option (right to buy)
Common Stock
38.30K shares
Shares
+38.30K
Strike price
16.00
Held after
38.30K
Exercisable
—
Series A-1 Preferred Stock
Common Stock
16.88M shares
Shares
−16.88M
Strike price
Held after
0.00
Exercisable
—
Series B Preferred Stock
Common Stock
4.15M shares
Shares
−4.15M
Strike price
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock38.30K shares | 4/16/2026 | A · Award | +38.30K | 16.00 | — | 38.30K |
| Series A-1 Preferred Stock Indirect | Common Stock16.88M shares | 4/20/2026 | C · Conversion | −16.88M | — | 0.00 | |
| Series B Preferred Stock Indirect | Common Stock4.15M shares | 4/20/2026 | C · Conversion | −4.15M | — | 0.00 |